| For the Year Ended June 30, 2024 | October 17, 2022 to June 30, 2023 (Successor) | June 30, 2022 to October 16, 2022 (Predecessor) | ||||||||||
| Cash flows from operating activities | ||||||||||||
| Net loss | $ | (2,281,742) | $ | (5,023,207) | $ | (320,064) | ||||||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||||||
| Depreciation and amortization | 155,059 | 109,144 | 6,420 | |||||||||
| Accretion of note payable discount | 5,250 | 12,750 | - | |||||||||
| Non cash interest expense | 85,593 | 152,684 | - | |||||||||
| Stock based compensation | 670,958 | 4,119,321 | - | |||||||||
| Non cash lease expense | 5,308 | 19,864 | - | |||||||||
| Imputed interest | - | - | 125,728 | |||||||||
| Provision for bad debt and write-off of on uncollectable accounts | 37,498 | 8,641 | 9,772 | |||||||||
| Changes in operating assets and liabilities: | ||||||||||||
| Accounts receivable | (271,224) | (107,942) | 101,423 | |||||||||
| Inventory | (211) | 475,009 | (157,596) | |||||||||
| Due from related parties, net | - | - | 4,686 | |||||||||
| Prepaid expenses | 80,301 | (139,563) | 4,747 | |||||||||
| Deferred revenue | 10,395 | - | 63,701 | |||||||||
| Accounts payable and accrued liabilities | (45,065) | 136,429 | 43,932 | |||||||||
| Net cash used in operating activities | (1,547,880) | (236,870) | (117,251) | |||||||||
| Investing activities | ||||||||||||
| Purchase of property and equipment | (10,438) | (1,260) | - | |||||||||
| Cash used in acquisition | - | (2,000,000) | (7,882) | |||||||||
| Net cash used in investing activities | (10,438) | (2,001,260) | (7,882) | |||||||||
| Financing activities | ||||||||||||
| Proceeds from issuance of series seed preferred stock | - | 1,000,000 | - | |||||||||
| Proceeds from issuance of class A common stock | - | 100 | - | |||||||||
| Proceeds from issuance of class B common stock | - | 1,650,000 | - | |||||||||
| Proceeds from issuance of class B common stock pursuant to Initial Public Offering, net of issuance costs | 4,233,875 | - | - | |||||||||
| Proceeds from issuance of convertible notes | 225,000 | - | - | |||||||||
| Payments from issuance of loans from related parties | - | 208,900 | 164,917 | |||||||||
| Payments for deferred offering costs | (587,573) | (227,676) | - | |||||||||
| Repayments of long term debt | - | - | (1,278) | |||||||||
| Payment on note payable | (480,667) | - | - | |||||||||
| Repayments of loans due to related parties | (208,900) | - | (288,861) | |||||||||
| Net cash provided by (used in) financing activities | 3,181,735 | 2,631,324 | (125,222) | |||||||||
| Net increase (decrease) in cash | 1,623,417 | 393,194 | (250,355) | |||||||||
| Cash and cash equivalents at beginning of year | 393,194 | - | 263,506 | |||||||||
| Cash and cash equivalents at the end of year | $ | 2,016,611 | $ | 393,194 | $ | 13,151 | ||||||
| Supplementary cash flow disclosure | ||||||||||||
| Interest paid | $ | 436,346 | $ | 14,438 | $ | 10 | ||||||
| Unpaid deferred offering costs | $ | - | $ | 75,079 | $ | - | ||||||
| Shares issued for conversion from convertible note payable | $ | 257,480 | $ | - | $ | - | ||||||
| Nine Months Ended March 31, 2023 | ||||||||||||
| Nine Months Ended March 31, 2024 (Successor) | October 17, 2022 to March 31, 2023 (Successor) | July 1, 2022 to October 16, 2022 (Predecessor) | ||||||||||
| Cash flows from operating activities | ||||||||||||
| Net loss | $ | (1,302,763) | $ | (4,509,093) | $ | (320,064) | ||||||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||||||
| Depreciation and amortization | 115,885 | 72,082 | 6,420 | |||||||||
| Accretion of note payable discount | 5,250 | 12,750 | - | |||||||||
| Non cash interest expense | 223,783 | 100,117 | - | |||||||||
| Stock based compensation | 151,981 | 3,997,442 | - | |||||||||
| Non cash lease expense | 5,342 | 19,373 | - | |||||||||
| Imputed interest | - | - | 125,728 | |||||||||
| Provision for bad debt and write-off of on uncollectable accounts | 29,923 | 8,641 | 9,772 | |||||||||
| Changes in operating assets and liabilities: | ||||||||||||
| Accounts receivable | (92,417) | (455,599) | 101,423 | |||||||||
| Inventory | (103,569) | 332,355 | (157,596) | |||||||||
| Due from related parties, net | - | - | 4,686 | |||||||||
| Prepaid expenses | 94,776 | (16,377) | 4,747 | |||||||||
| Deferred revenue | - | - | 63,701 | |||||||||
| Accounts payable and accrued liabilities | 386,279 | 269,242 | 43,932 | |||||||||
| Net cash used in operating activities | (485,530) | (169,067) | (117,251) | |||||||||
| Cash flows from investing activities | ||||||||||||
| Cash used in acquisition | - | (2,000,000) | - | |||||||||
| Purchase of property and equipment | (2,138) | - | (7,882) | |||||||||
| Net cash used in investing activities | (2,138) | (2,000,000) | (7,882) | |||||||||
| Cash flows from financing activities | ||||||||||||
| Payments for deferred offering costs | (124,458) | (150,683) | - | |||||||||
| Proceeds from issuance of series seed preferred stock | - | 1,000,000 | - | |||||||||
| Proceeds from issuance of class A common stock | - | 100 | - | |||||||||
| Proceeds from issuance of class B common stock | - | 1,650,000 | - | |||||||||
| Proceeds from issuance of convertible debt notes | 225,000 | - | - | |||||||||
| Repayments of long term debt | - | - | (1,278) | |||||||||
| Proceeds from issuance of loans from related parties | 50,014 | 234,566 | 164,917 | |||||||||
| Repayments of loans due to related parties | - | - | (288,861) | |||||||||
| Net cash provided by (used in) financing activities | 150,556 | 2,733,983 | (125,222) | |||||||||
| Net increase (decrease) in cash | (337,112) | 564,916 | (250,355) | |||||||||
| Cash at beginning of period | 393,194 | - | 263,506 | |||||||||
| Cash at the end of period | $ | 56,082 | $ | 564,916 | $ | 13,151 | ||||||
| Supplementary cash flow disclosure | ||||||||||||
| Interest paid | $ | 9,322 | $ | 13,376 | $ | 10 | ||||||
| Unpaid deferred offering costs | $ | 346,536 | $ | 45,546 | $ | - | ||||||
